PHARMACYTE BIOTECH INC (PMCB) Top Institutional Shareholders
PHARMACYTE BIOTECH INC (PMCB) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $602,220 in PMCB holdings during the latest filing period.
Citadel Advisors Llc is currently the largest disclosed institutional shareholder of PMCB tracked by InsiderSet, reporting ownership valued at approximately $239,243 in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $283,035.398, representing an estimated gain of +18.30% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 93% of the total disclosed PMCB value among the investors covered in this analysis. Major shareholders include Citadel Advisors Llc, Geode Capital Management, Llc, Renaissance Technologies LLC, and several other long-term asset managers with concentrated positions in PHARMACYTE BIOTECH INC (PMCB).
This page ranks the largest institutional PMCB shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
31
Total Reported Value
$602,220
Largest Holder
Citadel Advisors Llc
Largest Position
$239,243
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
37
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | 0.00% | 359,547 | $239,243 | $283,035 | +$43,792 | +18.30% | |
| Geode Capital Management, Llc | 0.00% | 195,660 | $130,200 | $154,024 | +$23,824 | +18.30% | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 56,500 | $37,595 | $44,477 | +$6,882 | +18.31% |
| Xtx Topco Ltd | 0.00% | 52,362 | $34,842 | $41,219 | +$6,377 | +18.30% | |
| Vanguard Capital Management Llc | 0.00% | 51,467 | $34,226 | $40,515 | +$6,289 | +18.37% | |
| Northern Trust Corp | 0.00% | 35,601 | $23,689 | $28,025 | +$4,336 | +18.30% | |
| Schonfeld Strategic Advisors Llc | 0.00% | 27,009 | $17,971 | $21,261 | +$3,290 | +18.31% | |
| Vanguard Fiduciary Trust Co | 0.00% | 23,452 | $15,596 | $18,461 | +$2,865 | +18.37% | |
| Equitec Proprietary Markets, Llc | 0.03% | 22,227 | $14,790 | $17,497 | +$2,707 | +18.30% | |
| Simplex Trading, Llc | 0.00% | 19,940 | $13,260 | $15,697 | +$2,437 | +18.38% | |
| Two Sigma Securities, Llc | 0.00% | 16,360 | $10,886 | $12,879 | +$1,993 | +18.30% | |
| Jane Street Group, Llc | 0.00% | 11,530 | $7,672 | $9,076 | +$1,404 | +18.31% | |
| Ground Swell Capital, Llc | 0.02% | 11,527 | $7,670 | $9,074 | +$1,404 | +18.31% | |
| Commonwealth Equity Services, Llc | 0.00% | 10,313 | $6,860 | $8,118 | +$1,258 | +18.34% | |
| Tower Research Capital Llc (Trc) | 0.00% | 4,889 | $3,253 | $3,849 | +$596 | +18.31% | |
| Ubs Group Ag | 0.00% | 4,519 | $3,005 | $3,557 | +$552 | +18.38% | |
| Group One Trading Llc | 0.00% | 1,785 | $1,188 | $1,405 | +$217 | +18.28% | |
| Osaic Holdings, Inc. | 0.00% | 302 | $200 | $238 | +$38 | +18.87% | |
| Virtu Financial Llc | 0.00% | 37,532 | $25 | $29,545 | +$29,520 | +118080.76% | |
| Hrt Financial Lp | 0.00% | 24,741 | $16 | $19,476 | +$19,460 | +121625.72% | |
| Sachetta, Llc | 0.00% | 14 | $10 | $11 | +$1 | +10.21% | |
| Western Wealth Management, Llc | 0.00% | 13 | $9 | $10 | +$1 | +13.71% | |
| Bfsg, Llc | 0.00% | 5 | $4 | $4 | -$0 | -1.60% | |
| Financial Consulate, Inc | 0.00% | 2 | $2 | $2 | -$0 | -21.28% | |
| Sbi Securities Co., Ltd. | 0.00% | 3 | $2 | $2 | +$0 | +18.08% | |
| Abound Wealth Management | 0.00% | 1 | $1 | $1 | -$0 | -21.28% | |
| Blackrock, Inc. | 0.00% | 1 | $1 | $1 | -$0 | -21.28% | |
| Cwm, Llc | 0.00% | 1 | $1 | $1 | -$0 | -21.28% | |
| Johnson Financial Group, Inc. | 0.00% | 1 | $1 | $1 | -$0 | -21.28% | |
| Mcf Advisors Llc | 0.00% | 1 | $1 | $1 | -$0 | -21.28% | |
| Morgan Stanley | 0.00% | 1 | $1 | $1 | -$0 | -21.28% |
Frequently asked questions about PMCB
Who owns the most PMCB stock?
The largest holders of PMCB are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for PHARMACYTE BIOTECH INC (PMCB).
Is PMCB widely held by superinvestors?
Many widely followed stocks like PMCB appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly PMCB is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.